Cravath, Swaine & Moore, McDermott Will & Emery and Skadden, Arps, Slate, Meagher & Flom have advised Aon. Aon has entered into a definitive agreement to...
Aon Signs Agreement to Acquire USI for $17 Billion
Sheridan Capital Partners Invests in Tres Health
McDermott Will & Schulte has advised Sheridan Capital Partners. Sheridan Capital Partners has completed an investment in Tres Health, a national alternative health insurance and technology...
Quad-C Management Invests in Dane Street
McDermott Will & Schulte has advised Quad-C Management, Inc. Latham & Watkins LLP has advised Dane Street, LLC. Quad-C Management, Inc., a prominent middle-market private equity...
Amulet’s Investment in Theoria Management
McDermott, Will & Emery served as legal counsel to Amulet on the deal. Amulet Capital Partners (Amulet), a middle-market private equity investment firm focused exclusively on...
FluoRok’s £7.7 Million Oversubscribed Funding Round
Wilson Sonsini Goodrich & Rosati advised FluoRok on patent matters related to the transaction. FluoRok, a deep-tech start-up focused on fluorochemical manufacturing, announced the completion of...
Ripple Therapeutics’ License Agreement with AbbVie
Wilson Sonsini Goodrich & Rosati advised Ripple on the transaction. Ripple Therapeutics Corporation (Ripple) announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a...
ONL Therapeutics’ $65 Million Series D Financing Round
Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters. ONL Therapeutics, Inc. announced...
BPD’s Acquisition of Revive Marketing
McDermott Will & Emery LLP acted as legal advisor to BPD on the transaction. BPD, the premier data-driven health system marketing services company in the United...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
General Atlantic’s $179 Million Investment into Gravie
McDermott Will & Emery represented General Atlantic in the transaction. General Atlantic, a leading global growth equity investor, executed its $179 million growth investment into Gravie,...
Vytalize Health’s Acquisition of Independent Physician Association of New York
McDermott Will & Emery represented Vytalize Health in the transaction. Vytalize Health, a leading risk-bearing provider enablement platform, announced its acquisition of Independent Physician Association of...